Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v3.2.0.727
Licenses Acquired (Tables)
6 Months Ended
Jun. 30, 2015
Research and Development [Abstract]  
Research and Development Arrangement, Contract to Perform for Others
For the six months ended June 30, 2015, the Company’s research and development-licenses is made up of the following:
 
 
 
For the Six Months
 
($ in thousands)
 
Ended June 30, 2015
 
Fortress:
 
 
 
 
EGFR inhibitors
 
$
1,000
 
IV Tramadol (1)
 
 
3,000
 
 
 
 
 
 
Fortress Companies:
 
 
 
 
Mustang
 
 
2,147
 
Checkpoint
 
 
1,033
 
Coronado SO
 
 
1,607
 
Helocyte
 
 
200
 
Total
 
$
8,987
 
 
(1) The Company intends to transfer this license to Avenue.